Trial · NCT03763318
Adverse events774
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 774
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Oedema peripheral | General disorders | EQ001 Dose Escalation (Part A) 0.4mg/kg | 2 | 4 | 2 |
| other | Oedema peripheral | General disorders | EQ001 Dose Escalation (Part A) 0.8mg/kg | 9 | 17 | 9 |
| other | Oedema peripheral | General disorders | EQ001 Dose Escalation (Part A) 1.6mg/kg | 6 | 9 | 6 |
| other | Fatigue | General disorders | EQ001 Dose Escalation (Part A) 0.4mg/kg | 1 | 4 | 1 |
| other | Fatigue | General disorders | EQ001 Dose Escalation (Part A) 0.8mg/kg | 6 | 17 | 6 |
| other | Fatigue | General disorders | EQ001 Dose Escalation (Part A) 1.6mg/kg | 3 | 9 | 3 |
| other | Chills | General disorders | EQ001 Dose Escalation (Part A) 0.4mg/kg | 1 | 4 | 1 |
| other | Chills | General disorders | EQ001 Dose Escalation (Part A) 0.8mg/kg | 1 | 17 | 1 |
| other | Chills | General disorders | EQ001 Dose Escalation (Part A) 1.6mg/kg | 1 | 9 | 1 |
| other | Generalised oedema | General disorders | EQ001 Dose Escalation (Part A) 0.4mg/kg | 0 | 4 | 0 |
| other | Generalised oedema | General disorders | EQ001 Dose Escalation (Part A) 0.8mg/kg | 2 | 17 | 2 |
| other | Generalised oedema | General disorders | EQ001 Dose Escalation (Part A) 1.6mg/kg | 1 | 9 | 1 |
| other | Asthenia | General disorders | EQ001 Dose Escalation (Part A) 0.4mg/kg | 0 | 4 | 0 |
| other | Asthenia | General disorders | EQ001 Dose Escalation (Part A) 0.8mg/kg | 1 | 17 | 1 |
| other | Asthenia | General disorders | EQ001 Dose Escalation (Part A) 1.6mg/kg | 1 | 9 | 1 |
| other | Pyrexia | General disorders | EQ001 Dose Escalation (Part A) 0.4mg/kg | 1 | 4 | 1 |
| other | Pyrexia | General disorders | EQ001 Dose Escalation (Part A) 0.8mg/kg | 0 | 17 | 0 |
| other | Pyrexia | General disorders | EQ001 Dose Escalation (Part A) 1.6mg/kg | 1 | 9 | 1 |
| other | Hypokalaemia | Metabolism and nutrition disorders | EQ001 Dose Escalation (Part A) 0.4mg/kg | 0 | 4 | 0 |
| other | Hypokalaemia | Metabolism and nutrition disorders | EQ001 Dose Escalation (Part A) 0.8mg/kg | 3 | 17 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03763318/events